3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Nasopharyngeal Carcinoma
14
Triple Negative Breast Neoplasms
12
Carcinoma, Non-Small-Cell Lung
10
Esophageal Squamous Cell Carcinoma
9
Breast Neoplasms
8
Colorectal Neoplasms
7
Carcinoma, Renal Cell
7
Small Cell Lung Carcinoma
6
Neoplasms
6
Advanced Solid Tumor
6
Uterine Cervical Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Head and Neck Neoplasms
5
Urinary Bladder Neoplasms
4
Recurrence
4
Carcinoma, Hepatocellular
4
Stomach Neoplasms
3
Solid Tumor
3
Neoplasm Metastasis
3
Liver Neoplasms
3
Carcinoma, Transitional Cell
3
Turcot syndrome
2
Sarcoma
2
Oropharyngeal Neoplasms
2
Nasopharyngeal Neoplasms
2
NSCLC
2
Muscle Invasive Bladder Cancer (MIBC)
2
Carcinoma, Squamous Cell
2
Biliary Tract Neoplasms
2
Advanced Solid Tumors
2
Interventions
pembrolizumab
27
Oxaliplatin
24
Paclitaxel
22
Fluorouracil
21
Carboplatin
18
Leucovorin
16
Cisplatin
16
Capecitabine
16
Radiotherapy
15
Nivolumab
12
Drug Therapy
12
Radiation
10
Trastuzumab
9
Surgical Procedures, Operative
9
Immunotherapy
8
Magnetic Resonance Spectroscopy
7
Esophagectomy
7
Blood Specimen Collection
7
Taxes
6
durvalumab
5
Surveys and Questionnaires
5
Specimen Handling
5
Radiotherapy, Intensity-Modulated
5
Irinotecan
5
Immune Checkpoint Inhibitors
5
Docetaxel
5
Bevacizumab
5
tislelizumab
4
Ramucirumab
4
Fluorodeoxyglucose F18
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Esophageal Neoplasms
×
toripalimab
×
1 year
×
Clear all
NCT07177794
2026-04-21
EC-CRT-008
Sun Yat-sen University
Phase 3
Recruiting
242 enrolled